FOXO TECHNOLOGIES INC

OPTIMI HEALTH CORP

HCW Biologics

Silexion Therapeutics

Vida Global

GCL Global

BiomX

MetaVia

Micware

MicroAlgo

FOXOW

Earnings Watch

FOXO TECHNOLOGIES INC | 10-K: FY2025 Revenue: USD 16.37 M

SBIO

FOXO

<p>FOXO Technologies Expands Authorized Class A Share Capacity</p>

Tip Ranks

SPDR S&P Biotech

VG Health

First Trust NYSE Arca Biotech Index Fd

ALPS Medical Breakthrough

iShares US Healthcare Providers

SPDR S&P Health

FOXO Tech

VanEck Biotech ETF

Invesco Biotechnology & Genome ETF

Direxion S&P Biotech Bull 3X

Health Care Select Sector SPDR

iShares Global Healthcare

iShares Biotechnology ETF

FOXO Technologies Expands Authorized Class A Share Capacity

<p>FOXO Technologies has signed a Series E Preferred Stock Exchange Agreement with Rennova Health to convert $200,000 in cash advances into equity. The company will issue 8,000 shares of Series E Cumulative Redeemable Secured Preferred Stock at $25.00 per share, fully satisfying and cancelling the prior advances. This private placement agreement was effective on December 31, 2025, allowing FOXO to extinguish debt and convert short-term advances to preferred equity.</p>

TradingView

Proshares Ultra Nasdaq Biotech

Rennova Health, Inc.

FOXO Technologies Signs Series E Preferred Stock Exchange Agreement With Rennova Health

FOXO TECHNOLOGIES INC | 10-Q: FY2025 Q3 Revenue: USD 3.548 M

FOXO TECHNOLOGIES INC | 10-Q: FY2025 Q2 Revenue: USD 5.218 M

FOXO TECHNOLOGIES INC | 10-Q: FY2025 Q1 Revenue: USD 3.17 M